These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 25416282)
1. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N. Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282 [TBL] [Abstract][Full Text] [Related]
2. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition. Kadgien CA; Kamesh A; Milnerwood AJ Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877 [TBL] [Abstract][Full Text] [Related]
3. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer. Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121 [TBL] [Abstract][Full Text] [Related]
4. Role of the VPS35 D620N mutation in Parkinson's disease. Mohan M; Mellick GD Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832 [TBL] [Abstract][Full Text] [Related]
5. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant. Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683 [TBL] [Abstract][Full Text] [Related]
6. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203 [TBL] [Abstract][Full Text] [Related]
7. VPS35 and retromer dysfunction in Parkinson's disease. Rowlands J; Moore DJ Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease-linked Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285 [TBL] [Abstract][Full Text] [Related]
9. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502 [TBL] [Abstract][Full Text] [Related]
10. VPS35 regulates cell surface recycling and signaling of dopamine receptor D1. Wang C; Niu M; Zhou Z; Zheng X; Zhang L; Tian Y; Yu X; Bu G; Xu H; Ma Q; Zhang YW Neurobiol Aging; 2016 Oct; 46():22-31. PubMed ID: 27460146 [TBL] [Abstract][Full Text] [Related]
11. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. Williams ET; Glauser L; Tsika E; Jiang H; Islam S; Moore DJ Hum Mol Genet; 2018 Sep; 27(18):3189-3205. PubMed ID: 29893854 [TBL] [Abstract][Full Text] [Related]
15. VPS35, the Retromer Complex and Parkinson's Disease. Williams ET; Chen X; Moore DJ J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538 [TBL] [Abstract][Full Text] [Related]
16. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease. Chen X; Tsika E; Levine N; Moore DJ Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299 [TBL] [Abstract][Full Text] [Related]
17. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N. Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646 [TBL] [Abstract][Full Text] [Related]
18. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP. Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388 [TBL] [Abstract][Full Text] [Related]
19. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649 [TBL] [Abstract][Full Text] [Related]